Corleen M. Roche

Chief Financial Officer, Immunome Inc.

Companies

Iovance BiotherapeuticsChief financial officer Aug 8, 2025 to now¹
CG Oncology, Inc.Chief financial officer Jan 24, 2024 to Apr 16, 2026²
Immunome Inc.Chief financial officer Apr 21, 2021 to Jun 12, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Iovance Biotherapeutics IOVA28,757 shares⁴$423.3K at $14.72Aug 6, 2026
CG Oncology, Inc. CGON2,000 shares⁵$119.7K at $59.85Jan 29, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 6, 2026Shares withheld for tax 21,238 shares at $6.21 of Iovance Biotherapeutics⁴
Aug 6, 2026Exercised options 49,995 shares of Iovance Biotherapeutics⁴
Jan 29, 2024Bought 2,000 shares at $19.00 of CG Oncology, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIovance Biotherapeutics, Chief financial officer
2
SEC EDGARCG Oncology, Inc., Chief financial officer
3
SEC EDGARImmunome Inc., Chief financial officer
4
SEC EDGARIovance Biotherapeutics shares after the filing of Aug 6, 2026
5
SEC EDGARCG Oncology, Inc. shares after the filing of Jan 29, 2024